Patients with heart failure (HF) are predisposed to falls for a variety of reasons.
The historic Trans-Pacific Partnership negotiations finalized today could affect the cost of health care in significant ways.
Medication dispensing within the first few months of prescribing chronic therapy can precisely predict future patient adherence.
Sanofi has launched a generic version of the rheumatoid arthritis (RA) drug leflunomide (Arava).
Side effects may vary, and occasionally take an odd turn.
Jennifer L. Costello, PharmD, BCPS, BC-ADM, gives a few tips for pharmacists with patients on weight-loss medications, such as liraglutide and naltrexone/bupropion.
The latest stabbing of a pharmacist has renewed calls for tougher sentencing and increased policing to protect pharmacists.
The FDA has approved Juviderm Ultra XC for lip augmentation in adults ages 21 or older.
Hot button health care issues dominate many of the presidential contenders’ political platforms.
Summer was a busy season for FDA drug warnings.
A pharmacist in Nebraska has pleaded guilty to what is possibly the largest case of Medicaid fraud in the state.
Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Strategic Alliance Partners